Laurion Capital Management »

Xilio Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Xilio Therapeutics (XLO) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $64k 117k 0.55
2023-09-30 $294k 139k 2.11
2023-06-30 $374k 143k 2.62
2023-03-31 $454k 143k 3.18
2022-12-31 $384k 143k 2.69
2022-09-30 $416k 143k 2.91
2022-06-30 $417k 143k 2.92

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Abbvie Put Option (ABBV)
Blackrock (BLK)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Goldman Sachs (GS)
Alphabet Cap Stk Cl C (GOOG)
Texas Instruments Incorporated (TXN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Strategy Cl A New Call Option (MSTR)
International Business Machines (IBM)
NVIDIA Corporation Call Option (NVDA)
Honeywell International (HON)

View all positions for Laurion Capital Management

Top funds holding Xilio Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
Merck & Co
Takeda Pharmaceutical
Vanguard Group
AJU IB Investment
FMR
Geode Capital Management
Squarepoint Ops
Trustees of Columbia University in the City of New York
Renaissance Technologies
Balyasny Asset Management
State Street Corporation
Two Sigma Investments
XTX Topco

View all funds holding Xilio Therapeutics